A detailed history of Northeast Financial Consultants Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 2,006 shares of NVO stock, worth $175,825. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,006
Previous 1,768 13.46%
Holding current value
$175,825
Previous $252,000 5.56%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$119.07 - $145.42 $28,338 - $34,609
238 Added 13.46%
2,006 $238,000
Q2 2024

Aug 15, 2024

BUY
$122.71 - $146.91 $216,951 - $259,736
1,768 New
1,768 $252,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.